---
title: "PSP NIH-CurePSP-Tau WGS"
id: "2411"
type: "sample_set"
slug: "snd10015"
published_at: "2021-02-24T01:10:16+00:00"
modified_at: "2023-12-14T22:29:39+00:00"
url: "https://dss.niagads.org/sample-sets/snd10015/"
markdown_url: "https://dss.niagads.org/sample-sets/snd10015.md"
excerpt: "PSP NIH, CurePSP and Tau consortium samples were whole-genome sequenced at USUHS on the HiSeqX machine. FASTQ files were sent to GCAD for processing on the VCPA1.1 pipeline. 617 samples passed sequencing metrics and quality control."
---

## Description

PSP NIH, CurePSP and Tau consortium samples were whole-genome sequenced at USUHS on the HiSeqX machine. FASTQ files were sent to GCAD for processing on the VCPA1.1 pipeline. 617 samples passed sequencing metrics and quality control.

## Cohorts

- [NIA Alzheimer's Disease Research Centers (ADRC)](https://dss.niagads.org/cohorts/nia-alzheimers-disease-research-centers-adrc/)
- [Progressive Supranuclear Palsy (PSP)](https://dss.niagads.org/cohorts/progressive-supranuclear-palsy-psp/)

## Sex

### Total number of samples: 617

Female25942.0 %

Male35858.0 %

## Race

### Total number of samples: 617

| Asian | 1 |
| --- | --- |
| White | 611 |
| Other | 5 |

## Ethnicity

### Total number of samples: 617

Not Hispanic or Latino

2

0.3%

Not Applicable/Not Available

615

99.7%

## Diagnosis

### Total number of samples: 617

| AD |  |  |
| --- | --- | --- |
| Control | 1 | 0.2% |
| Case | 1 | 0.2% |

| PSP |  |  |
| --- | --- | --- |
| Case | 615 | 99.7% |

## APOE

### Total number of samples: 617

- 231 (0.2%)
- 341 (0.2%)
- NA615 (99.7%)